Trial intelligence / Profile preview

Oral plus intravenous versus intravenous-only antibiotic prophylaxis in elective colon surgery

2014-002345-21Phase 4Completed

Sponsor
Dr Eloy Espin
Start
Oct 2014
Modality
Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of ciprofloxacin, metronidazole and cefuroxime in surgical site infection (SSI) (2 arms), sponsored by Dr Eloy Espin. Primary endpoints: surgical site infection and perioperative complications. Started Oct 2014; status: completed.

02

Drugs

ciprofloxacinmetronidazolecefuroxime
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on 2014-002345-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-002345-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call